Layton H. Smith

4.4k total citations
93 papers, 3.1k citations indexed

About

Layton H. Smith is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Layton H. Smith has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Layton H. Smith's work include Effects of Radiation Exposure (9 papers), Nuclear Receptors and Signaling (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers). Layton H. Smith is often cited by papers focused on Effects of Radiation Exposure (9 papers), Nuclear Receptors and Signaling (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers). Layton H. Smith collaborates with scholars based in United States, Australia and Italy. Layton H. Smith's co-authors include Douglas E. Vaughan, Bart De Taeye, P. Mazur, Michael G. Hanna, S.P. Leibo, J. Farrant, Khandaker Siddiquee, Wooin Lee, Richard B. Kim and Hartmut Glaeser and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Layton H. Smith

88 papers receiving 3.0k citations

Peers

Layton H. Smith
Jane F Armstrong United Kingdom
F Markwárdt Germany
B. L. Brown United Kingdom
Timothy G. Hammond United States
Jonathan M. Gibbins United Kingdom
David B. P. Goodman United States
Layton H. Smith
Citations per year, relative to Layton H. Smith Layton H. Smith (= 1×) peers Tomoko Kita

Countries citing papers authored by Layton H. Smith

Since Specialization
Citations

This map shows the geographic impact of Layton H. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Layton H. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Layton H. Smith more than expected).

Fields of papers citing papers by Layton H. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Layton H. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Layton H. Smith. The network helps show where Layton H. Smith may publish in the future.

Co-authorship network of co-authors of Layton H. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Layton H. Smith. A scholar is included among the top collaborators of Layton H. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Layton H. Smith. Layton H. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pinkerton, Anthony B., E. Hampton Sessions, Paul Hershberger, et al.. (2021). Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators. Bioorganic & Medicinal Chemistry Letters. 41. 128007–128007. 15 indexed citations
3.
Battista, Sabrina, Alyssa Garabedian, Alfredo Fusco, et al.. (2020). Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays. Scientific Reports. 10(1). 18850–18850. 23 indexed citations
4.
Peddibhotla, Satyamaheshwar, Paul Hershberger, R. Jason Kirby, et al.. (2019). Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma. Bioorganic & Medicinal Chemistry Letters. 30(4). 126899–126899. 15 indexed citations
5.
Pinkerton, Anthony B., Satyamaheshwar Peddibhotla, Lauren M. Slosky, et al.. (2019). Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators. Journal of Medicinal Chemistry. 62(17). 8357–8363. 32 indexed citations
6.
Bassoni, Daniel L., András Szabó, Haleli Sharir, et al.. (2018). A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors. Assay and Drug Development Technologies. 16(7). 384–396. 3 indexed citations
7.
Brown, Jacob D., et al.. (2018). Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 315(4). R595–R608. 12 indexed citations
8.
Siddiquee, Khandaker, András Szabó, Stefan Vasile, et al.. (2018). Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization. PLoS ONE. 13(9). e0202436–e0202436. 11 indexed citations
9.
Rai, Rahul, Asish K. Ghosh, Mesut Eren, et al.. (2017). Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan. Cell Reports. 21(6). 1471–1480. 62 indexed citations
10.
Kirby, R. Jason, et al.. (2016). Assessment of drug-induced arrhythmic risk using limit cycle and autocorrelation analysis of human iPSC-cardiomyocyte contractility. Toxicology and Applied Pharmacology. 305. 250–258. 4 indexed citations
11.
Moussaud, Simon, et al.. (2015). Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies. Expert Opinion on Therapeutic Targets. 19(5). 589–603. 26 indexed citations
12.
Dhanya, Raveendra-Panickar, Douglas J. Sheffler, Russell Dahl, et al.. (2014). Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence. Journal of Medicinal Chemistry. 57(10). 4154–4172. 26 indexed citations
13.
Markant, Shirley L., Lourdes Adriana Esparza, Marat S. Pavlyukov, et al.. (2014). Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene. 34(29). 3770–3779. 49 indexed citations
14.
Teriete, Peter, Russell Dahl, Tina Kiffer-Moreira, et al.. (2014). Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1. Bioorganic & Medicinal Chemistry Letters. 24(17). 4308–4311. 21 indexed citations
15.
Sugarman, Eliot, Ada Koo, Eigo Suyama, et al.. (2013). Identification of Inhibitors of Triacylglyceride Accumulation in Muscle Cells: Comparing HTS Results from 1536-Well Plate-Based and High-Content Platforms. SLAS DISCOVERY. 19(1). 77–87. 5 indexed citations
16.
Preuss, Janina, Eduard Sergienko, Anthony B. Pinkerton, et al.. (2012). High-Throughput Screening for Small-Molecule Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase 6-Phosphogluconolactonase. SLAS DISCOVERY. 17(6). 738–751. 23 indexed citations
17.
Siddiquee, Khandaker, et al.. (2011). Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. Journal of Hypertension. 29(4). 724–731. 85 indexed citations
18.
Lee, Wooin, Hartmut Glaeser, Layton H. Smith, et al.. (2005). Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2). Journal of Biological Chemistry. 280(10). 9610–9617. 284 indexed citations
19.
Pierce, Sidney K., et al.. (1989). Evidence of calmodulin involvement in cell volume recovery following hypo-osmotic stress. Cell Calcium. 10(3). 159–169. 29 indexed citations
20.
Hofmann, I., I. Haber, L.J. Laslett, & Layton H. Smith. (1983). STABILITY OF THE KAPCHINSKIJ-VLADIMIRSKIJ (K-V) DISTRIBUTION IN LONG PERIODIC TRANSPORT SYSTEMS. CERN Bulletin. 13. 145–178. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026